Therefore, ALPK2 exerts a cancer-promoting role in the development of bladder cancer by regulating DEPDC1A, which may become a promising target to improve the treatment strategy of bladder cancer. The gene discussed is DEPDC1; the disease is urinary bladder carcinoma.